Skip to content

Study for blood biomarkers of Alzheimer's disease

Study for blood biomarkers of Alzheimer's disease

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900027622
Enrollment
Unknown
Registered
2019-11-21
Start date
2019-12-01
Completion date
Unknown
Last updated
2019-11-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimer's disease

Interventions

Gold Standard:NIA-AA Alzheimer's Criteria(2011)
Index test:A&#32
beta&#32
40,&#32
A&#32
42,&#32
T-Tau,&#32
p-Tau,&#32
NFL,&#32
CHI3L1,&#32
H-FABP,&#32
TREM2,&#32
VILIP,&#32

Sponsors

Army Medical University Daping Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Age 55 or older (including 55 years old); 2) Willing to take venous blood collection and lumbar puncture; 3) Cognitive unimpaired (control group) Meets the diagnostic criteria for AD issued by the 2011 NIA-AA (AD group); 4) Willing to participate in the study and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1) Intracranial infection or systemic infection; 2) Cardiac diseases such as severe coronary heart disease, cardiac insufficiency, and atrial fibrillation; 3) Severe liver and kidney dysfunction; 4) Severe blood system diseases; 5) Central nervous system diseases such as acute stroke, intracranial tumor, and multiple sclerosis; 6) Advanced systemic malignant tumors.

Design outcomes

Primary

MeasureTime frame
Aß40;Tau;Aß42;p-Tau;NFL;SEN, SPE, ACC, AUC of ROC;

Countries

China

Contacts

Public ContactWang Yanjiang

Army Medical University Daping Hospital

wayaja@163.com+86 15023653506

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026